Companies / Crinetics Pharmaceuticals, Inc. / Activity
Activity — Crinetics Pharmaceuticals, Inc.
4 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Struthers Richard Scott CEO | Sell | Common Stock | $489.7K | -13K -3.09% | 413,563 0.39% of shares | medium |
| Mar 16, 2026 | Struthers Richard Scott CEO | Sell | Common Stock | $331.8K | -9K -2.12% | 404,778 0.38% of shares | medium |
| Feb 23, 2026 | Struthers Richard Scott CEO | Grant | Common Stock | $0 | +62K +17.00% | 426,759 0.40% of shares | low |
| Feb 23, 2026 | Struthers Richard Scott CEO | Grant | Stock Option (Right to Buy) | — | +228K | 228,000 0.21% of shares | low |